Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China · Delayed Price · Currency is CNY 7.93
-0.08 (-1.00%)
Jul 21, 2026, 3:00 PM CST
SHA:603707 Market Cap
SHA:603707 has a market cap or net worth of 12.8 billion as of July 21, 2026. Its market cap has decreased by -30.13% in one year.
Market Cap
12.80B
Enterprise Value
12.09B
Revenue
4.03B
Ranking
n/a
PE Ratio
22.16
Stock Price
7.93
ChartMarket Cap Chart
Since July 19, 2017, SHA:603707's market cap has increased from 4.40B to 12.80B, an increase of 191.21%. That is a compound annual growth rate of 12.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 12.80B | -12.26% |
| Dec 31, 2025 | 14.59B | -31.95% |
| Dec 31, 2024 | 21.44B | -11.29% |
| Dec 29, 2023 | 24.17B | -16.87% |
| Dec 30, 2022 | 29.08B | -44.15% |
| Dec 31, 2021 | 52.06B | 59.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Kangtai Biological Products | 13.56B |
| Harbin Pharmaceutical Group | 13.42B |
| Zhejiang Hisun Pharmaceutical | 13.11B |
| Shenzhen Hepalink Pharmaceutical Group | 13.00B |
| Zhejiang Jiuzhou Pharmaceutical | 12.75B |
| Henan Lingrui Pharmaceutical | 12.61B |
| Guobang Pharma | 12.52B |
| Shenzhen Chipscreen Biosciences | 12.38B |